Search for: "Dura Pharmaceuticals, Inc. v. Broudo"
Results 41 - 59
of 59
Sorted by Relevance
|
Sort by Date
23 Sep 2008, 3:34 am
This decision comes just two weeks after another panel of the same court cautioned, based on similar facts, that “[e]nabling a plaintiff to proceed on such a theory would effectively resurrect what Dura [Pharmaceuticals, Inc. v. [read post]
23 Sep 2008, 3:34 am
This decision comes just two weeks after another panel of the same court cautioned, based on similar facts, that “[e]nabling a plaintiff to proceed on such a theory would effectively resurrect what Dura [Pharmaceuticals, Inc. v. [read post]
2 Feb 2017, 9:53 am
Prior to his judicial service, Judge Gorsuch also wrote an amicus brief for the United States Chamber of Commerce in Dura Pharmaceuticals, Inc. v. [read post]
2 Feb 2017, 9:53 am
Prior to his judicial service, Judge Gorsuch also wrote an amicus brief for the United States Chamber of Commerce in Dura Pharmaceuticals, Inc. v. [read post]
21 May 2007, 4:43 pm
" Verizon Communications Inc. v. [read post]
7 Jun 2011, 7:44 am
See Dura Pharmaceuticals, Inc. v. [read post]
3 Oct 2014, 7:55 am
Fifth Circuit decision Citing the Supreme Court's ruling on loss causation in Dura Pharmaceuticals, Inc. v. [read post]
20 Mar 2008, 5:12 am
Based on Dura Pharmaceuticals, Inc. v. [read post]
24 Jun 2019, 7:44 pm
John Fund Inc. v. [read post]
15 Sep 2016, 12:51 pm
John Fund, Inc. v. [read post]
25 Feb 2009, 5:01 am
Charter Communications; and (2) some clarification on loss causation as articulated by the United States Supreme Court’s decision in Dura Pharmaceuticals, Inc. v. [read post]
3 Apr 2024, 9:05 pm
To limit damages to the inflation dissipated by corrective disclosures, as required by Dura Pharmaceuticals v. [read post]
11 Nov 2021, 2:07 pm
Nessim MezrahiIn the following guest post, Nessim Mezrahi takes a detailed look at the factors driving D&O profitability and the securities class action loss mitigation steps insurers can take to improve profitability. [read post]
4 Oct 2016, 6:55 pm
Vivendi argued that the price maintenance theory adopted by the district court contravenes the Supreme Court’s requirement that there must be a direct causal connection between the misrepresentation and the loss, citing Dura Pharmaceuticals, Inc. v. [read post]
18 Mar 2010, 2:47 pm
Id. at 526 (it is “not. . .proper to assume that the [plaintiff] can prove facts that it has not alleged or that the defendants [can be liable] in ways that have not been alleged”).More recently, in Dura Pharmaceuticals, Inc. v. [read post]
6 Jun 2007, 6:20 pm
" Id. at *30, citing Dura Pharmaceuticals, Inc. v. [read post]
24 Sep 2010, 3:08 pm
Title: Placer Dome, Inc. v. [read post]
20 Oct 2008, 10:23 am
I. [read post]
22 Feb 2016, 4:36 pm
In 1968, a court decision, Escott v. [read post]
